Healthcare upgrades for Monday

|By:, SA News Editor

McKesson (MCK -0.1%) upgraded to Strong Buy from Outperform at Raymond James.

DaVita (DVA +0.4%) upgraded to Outperform from Market Perform at Raymond James.

Idenix Pharmaceuticals (IDIX -0.3%) upgraded to Buy from Neutral at UBS.

Abbott Labs (ABT +1.5%) upgraded to Overweight from Equalweight at Morgan Stanley.

Medtronic (MDT +2%upgraded to Overweight from Neutral at JPMorgan. Price target is $69.

Vertex Pharmaceuticals (VRTX +2.5%) upgraded to Buy from Neutral at UBS.

Ocera Therapeutics (OCRX +2.7%) upgraded to Outperform from Market Perform at BMO.

Boston Scientific (BSX +3.2%upgraded to Overweight from Equalweight at Morgan Stanley.

Exelixis (EXEL +4.6%) upgraded to Overweight from Neutral at Piper.

St. Jude Medical (STJ +3.8%) upgraded to Overweight from Equalweight at Morgan Stanley.